Loading…

Prognostic Role of CMR in Patients Presenting With Ventricular Arrhythmias

Objectives The goal of this study was to explore whether fibrosis detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is an independent predictor of hard cardiovascular events in patients presenting with ventricular arrhythmia. Background In patients at risk of sudden cardia...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Cardiovascular imaging 2013-03, Vol.6 (3), p.335-344
Main Authors: Dawson, Dana K., DM, DPhil, Hawlisch, Karin, MD, Prescott, Gordon, PhD, Roussin, Isabelle, MD, Di Pietro, Elisa, MD, Deac, Monica, MD, Wong, Joyce, MD, Frenneaux, Michael P., MD, Pennell, Dudley J., MD, Prasad, Sanjay K., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives The goal of this study was to explore whether fibrosis detected by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is an independent predictor of hard cardiovascular events in patients presenting with ventricular arrhythmia. Background In patients at risk of sudden cardiac death, risk stratification for device therapy remains challenging. Methods A total of 373 consecutive patients with sustained ventricular tachycardia (VT) (n = 204) or nonsustained ventricular tachycardia (NSVT) (n = 169) underwent LGE-CMR. The group was prospectively followed up for a median of 2.6 years (range 11 months to 11 years). The predetermined endpoint was a composite of cardiac death/arrest, new episode of sustained VT, or appropriate implantable cardioverter-defibrillator discharge. Results Mean left ventricular (LV) ejection fraction (EF) was 60 ± 13%. The presence of fibrosis was a strong and independent predictor of the primary outcome for the whole group (hazard ratio [HR]: 3.3, 95% confidence interval [CI]: 1.8 to 5.8, p < 0.001). In the sustained VT subset, both LV fibrosis and severely impaired systolic function (LVEF
ISSN:1936-878X
1876-7591
DOI:10.1016/j.jcmg.2012.09.012